Cedars-Sinai Researchers Discover Specialized Neurons That Filter Experiences for Long-Term Storage, Opening New Paths for Alzheimer’s and Epilepsy Therapies
LOS ANGELES — Deep within the human temporal lobe lies a walnut-sized cluster of neurons historically famous for regulating fear and emotion. Now, groundbreaking research reveals that this structure—the amygdala—plays a far broader and more powerful role: acting as the brain’s master filter for long-term memory.
Published in the journal Nature Neuroscience, a new study led by investigators at Cedars-Sinai Health Sciences University demonstrates that the amygdala tags novel experiences for permanent storage, identifying it as a promising new therapeutic target for conditions like Alzheimer’s disease and temporal lobe epilepsy.
The Brain’s Selective Filter
For decades, neuroscientists believed the amygdala’s role in memory was strictly confined to emotionally charged or fear-inducing events. However, the new findings prove that the region serves as a general gateway for episodic memory.
The mechanism relies on specialized category-selective neurons within the amygdala that fire in response to specific visual stimuli, such as human faces, animals, or natural landscapes. According to the study, the intensity of a neuron’s electrical reaction directly correlates with how well an individual will remember that image later.
“This is an impactful study that provides mechanistic insight into the role of the human amygdala… in determining which experiences and stimuli become lasting episodic memories,” said Dr. Mauricio Rangel-Gomez, a program officer at the National Institutes of Health (NIH).
A Landmark Human Study Enabled by Collaboration
Gathering this level of high-resolution data in living humans is exceptionally rare. The discovery was made possible by analyzing single-neuron activity recorded from 112 surgical patients who had intracranial electrodes temporarily implanted to monitor intractable epileptic seizures.
During the trials, participants viewed unfamiliar images and were later tested on their recall. The vast dataset—replicated across two independent cohorts—was coordinated through a multi-institutional consortium funded by the NIH’s BRAIN (Brain Research Through Advancing Innovative Neurotechnologies) Initiative.
Senior investigator Dr. Ueli Rutishauser, professor of Neurosurgery at Cedars-Sinai, noted that the clinical implications are profound.
“The memory impairments seen in disorders such as Alzheimer’s disease and temporal lobe epilepsy might be partly due to disrupted processes within the amygdala,” Rutishauser said. “The amygdala might therefore be a suitable new target for treating these disorders using neuromodulation and/or cellular therapies.”
Looking Ahead: Beyond Vision
Dr. Jiayang Xiao served as the study’s first author, with contributions from researchers across multiple partner institutions.
Looking forward, the research team aims to determine whether the amygdala utilizes similar neural gating mechanisms for non-visual memories, such as auditory sounds and olfactory scents.
“Beyond the pure scientific value of these breakthroughs, we are laser-focused on applying this new knowledge to improving the lives of patients,” said Dr. Adam Mamelak, director of the Epilepsy and Functional Neurosurgery Program at Cedars-Sinai and co-author of the study.
